Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Colloidal Silver (NanoAgCideTM): Active Ingredient: Colloidal Silver (B.P.) 50 ppm
12 sprays on each hand -wait for 60 sec, rub hands for 30 seconds,
Control Intervention1: NA: NA
Sponsors
WeInnovate Biosolutions Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or Female aged 18 to 80 years (both inclusive) of age tested SARS-CoV-2 positive within last 8 days of study enrolment. 2. Patients willing to sign written informed consent and are ready to comply to study procedure. 3. SARS-CoV-2 positive asymptomatic or symptomatic patients who are under institutional quarantine.
Exclusion criteria
Exclusion criteria: 1. Patients requiring emergency treatment during enrolment. 2. Patients on ventilator support. 3. Pregnant or lactating woman. 4. Subjects with history of sun burn on hands. 5. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis, Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis. 6. Subjects on treatment of any degree burns. 7. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder communication with the research team. 8. Inability of the subject to cooperate or communicate with the research team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinically significant Quantitative Reduction of 80% Virus load from baseline to EOT. Timepoint: 90 secs | — |
Secondary
| Measure | Time frame |
|---|---|
| Time taken by the IP in Quantitative Reduction of Virus from baseline to EOT in a given period of time.Timepoint: 90 secs | — |
Countries
India
Contacts
Public ContactSubham Dutta
WeInnovate Biosolutions Pvt. Ltd
Outcome results
None listed